Drug Profile
Research programme: sterile injectable products - Eton Pharmaceuticals
Alternative Names: ACTH analogue - Eton Pharma; Corticotropin - Eton Pharma; CT-100; Injectable corticotropin - Eton; Injectable pentoxifylline - Eton; Pentoxifylline - Eton Pharma; Synthetic corticotropin - Eton PharmaLatest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator Imprimis Pharmaceuticals
- Developer Eton Pharmaceuticals
- Class Corticosteroids; Hypothalamic hormones; Small molecules; Xanthines
- Mechanism of Action Corticotropin receptor agonists; Cytokine inhibitors; Immunosuppressants; Phosphoric diester hydrolase inhibitors; Steroid receptor agonists; Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ankylosing spondylitis; Arthritis; Infantile spasms; Inflammation; Multiple sclerosis; Peyronie's disease
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for preclinical development in Ankylosing-spondylitis in USA (Injection)
- 28 Jun 2021 No recent reports of development identified for preclinical development in Arthritis in USA (Injection)
- 28 Jun 2021 No recent reports of development identified for preclinical development in Infantile spasms in USA (Injection)